BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08046876 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08046876\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07090499-2679@assetmemo.bio
DTSTAMP:20261121T005403Z
DTSTART;VALUE=DATE:20280708
DTEND;VALUE=DATE:20280709
SUMMARY:PF-08046876: Phase 1 readout est. (NCT07090499)
DESCRIPTION:PF-08046876\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A S
 tudy to Learn About the Study Medicine Called PF-08046876 in People With A
 dvanced Solid Tumors\nEstimated primary completion: 8 July 2028. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/pf-08046876#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07090499
URL:https://assetmemo.bio/drug/pf-08046876#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
